CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Patel Chintu Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +1,333,334 | 1,333,334 | ||
| 2024-03-04 | Patel Chirag K. President & Co-CEO | Grant or award · Restricted Stock Units | +370,370 | 370,370 | ||
| 2024-03-04 | Patel Chirag K. President & Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +1,333,334 | 1,333,334 | ||
| 2024-03-04 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Restricted Stock Units | +175,926 | 175,926 | ||
| 2024-03-04 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Performance-Based Restricted Stock Units | +351,852 | 351,852 | ||
| 2024-03-04 | Daly Jason B. SVP, Chief Legal Officer | Grant or award · Restricted Stock Units | +143,519 | 143,519 | ||
| 2024-03-04 | Daly Jason B. SVP, Chief Legal Officer | Grant or award · Performance-Based Restricted Stock Units | +287,038 | 287,038 | ||
| 2024-03-04 | BOYER ANDREW S Executive Vice President | Grant or award · Restricted Stock Units | +152,778 | 152,778 | ||
| 2024-03-04 | BOYER ANDREW S Executive Vice President | Grant or award · Performance-Based Restricted Stock Units | +305,556 | 305,556 | ||
| 2024-03-04 | Shah Nikita Executive Vice President | Grant or award · Restricted Stock Units | +143,519 | 143,519 | ||
| 2024-03-04 | Shah Nikita Executive Vice President | Grant or award · Performance-Based Restricted Stock Units | +287,038 | 287,038 | ||
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Option exercise | +45,290 | 449,070 | ||
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Shares withheld for taxes | −15,897 | $5.47 | $87K | 433,173 |
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Option exercise | +57,339 | 490,512 | ||
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Shares withheld for taxes | −20,126 | $5.47 | $110K | 470,386 |
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Option exercise · Restricted Stock Units | −45,290 | 90,580 | ||
| 2024-03-03 | Konidaris Tasos Executive Vice President & CFO | Option exercise · Restricted Stock Units | −57,339 | 172,019 | ||
| 2024-03-03 | Daly Jason B. SVP, Chief Legal Officer | Option exercise | +22,645 | 37,126 | ||
| 2024-03-03 | Daly Jason B. SVP, Chief Legal Officer | Shares withheld for taxes | −7,166 | $5.47 | $39K | 29,960 |
| 2024-03-03 | Daly Jason B. SVP, Chief Legal Officer | Option exercise | +38,226 | 68,186 |
Page 17 of 31 · 617 trades